raw materials – Page 28

Supplier change not evaluated during deviation investigation – CAPA to prevent repeat failures

Effective Strategies for Evaluating Supplier Changes During Deviation Investigations Changes in suppliers of raw materials can significantly impact the quality and safety of pharmaceutical products. When these changes are not…

Inadequate vendor qualification during requalification – inspection questions regulators ask

Investigating Issues with Vendor Qualification During Requalification In the pursuit of maintaining product quality, pharmaceutical manufacturers often face challenges arising from inadequate vendor qualification, particularly during the requalification process. Regulatory…

Specification change not communicated during routine operations – CAPA to prevent repeat failures

Addressing Uncommunicated Specification Changes during Routine Operations: A Comprehensive CAPA Playbook Specification changes that go uncommunicated during manufacturing operations can lead to significant quality issues, regulatory concerns, and increased operational…

Audit response ineffective during supplier onboarding – audit CAPA remediation framework

Addressing Ineffective Audit Responses During Supplier Onboarding: A Framework for Remediation In the pharmaceutical industry, the integrity of supplier onboarding processes is critical to maintaining compliance and ensuring the quality…

Change impact underestimated during routine operations – regulatory expectations for material changes

Understanding Regulatory Expectations for Material Changes in Routine Operations In the fast-paced environment of pharmaceutical manufacturing, routine operations often pave the way for product quality and compliance. However, the impact…

Audit response ineffective during requalification – inspection questions regulators ask

When Audit Responses Fall Short During Requalification: How to Investigate Effectively A common issue faced in pharmaceutical manufacturing is the unpreparedness of an audit response during requalification phases. Regulatory bodies…

Reference standard misuse during routine testing – inspection-ready justification strategy

Justifying Strategies Against Reference Standard Misuse During Routine Testing In the pharmaceutical industry, ensuring the integrity of quality control testing is vital for maintaining compliance with regulatory standards and for…

Reference standard misuse during supplier qualification – USP/EP/IP compliance gap analysis

Addressing the Misuse of Reference Standards During Supplier Qualification: A Comprehensive Investigation In the pharmaceutical manufacturing environment, the integrity of reference standards during supplier qualification plays a crucial role in…

Test method non-compliance during inspection – inspection-ready justification strategy

Addressing Test Method Non-Compliance During Regulatory Inspections In the pharmaceutical manufacturing sector, adherence to specified test methods is critical for compliance with regulatory standards. Non-compliance during inspections can lead to…

Reference standard misuse during submission support – USP/EP/IP compliance gap analysis

Analyzing Reference Standard Misuse During Submission Support: A Detailed Investigation In pharmaceutical manufacturing, ensuring compliance with pharmacopoeial standards such as USP, EP, and IP is critical. However, misuse of reference…

Unjustified in-house specification during audit review – USP/EP/IP compliance gap analysis

Addressing Unjustified In-House Specifications During Audit Reviews for USP/EP/IP Compliance In the pharmaceutical manufacturing landscape, in-house specifications that deviate from regulatory standards can lead to serious compliance risks during audits.…

Test method non-compliance during submission support – USP/EP/IP compliance gap analysis

Addressing Test Method Non-Compliance During Submission Support: A Structured Investigation During the submission process for pharmaceutical products, the detection of test method non-compliance can escalate into significant quality risks and…